Is Semaglutide available in India in 2026?

By the ZIVOLABS Medical Team · Updated April 2026 · 7 min read

Yes — semaglutide is available in India in 2026, and it has become significantly more accessible than ever before. Here is everything you need to know, including which brands are approved, how much they cost, and how to get a legitimate prescription.

What is semaglutide?

Semaglutide is the active ingredient in medications like Ozempic and Wegovy. It belongs to a class of drugs called GLP-1 receptor agonists. Originally developed to manage Type 2 diabetes, clinical trials showed that it also produces substantial, sustained weight loss — often 10–15% of total body weight over 6–12 months.

It works by mimicking a natural hormone that signals to your brain that you are full, slowing digestion and reducing appetite. It is not a stimulant or a diet pill. It is a prescription medication that changes the biology of hunger itself.

Important: Semaglutide is a Schedule H drug in India. This means it legally requires a prescription from a registered medical doctor. It cannot be purchased over the counter.

What changed in 2025–2026?

For years, the only semaglutide product available globally was Novo Nordisk's Ozempic, which was priced out of reach for most Indian patients — often ₹20,000 to ₹30,000 per month. That changed when Novo Nordisk's Indian patent exclusivity lapsed and the DCGI (Drug Controller General of India) approved generic semaglutide formulations.

Two Indian pharmaceutical companies now manufacture and sell DCGI-approved generic semaglutide injections in India:

• Alkem Laboratories — Semasize: Available in 0.25 mg, 0.5 mg, and 1 mg pre-filled pens

• Natco Pharma — Semanat: Available in 0.25 mg, 0.5 mg, and 1 mg pre-filled pens

Both are manufactured under Indian GMP standards and approved by India's central drug regulator. They contain the same active molecule as Ozempic.

How much does semaglutide cost in India in 2026?

This is where the situation has dramatically improved. Generic semaglutide has made the treatment accessible to a much broader population.

When accessed through a structured program like ZIVOLABS, semaglutide-based treatment — including doctor consultation, monitoring, and medication — starts at ₹4,999 per month.

Is it safe? Is it the real thing?

This is the most important question, and it deserves a direct answer.

The DCGI-approved generics from Alkem and Natco contain the same active molecule as the original branded product. The approval process requires them to demonstrate bioequivalence — meaning they behave the same way in the body. These are not counterfeit or unregulated products.

Warning: There are unregulated semaglutide products circulating online — particularly compounded versions and imports without DCGI approval. These carry genuine safety risks. Always ensure your medication is DCGI-approved and dispensed against a valid prescription.

Who can get semaglutide in India?

Semaglutide is approved in India for use in adults who meet one of the following criteria:

Your doctor will conduct a health assessment before prescribing. Semaglutide is not suitable for everyone — people with a personal or family history of medullary thyroid cancer, or certain pancreatic conditions, are typically excluded.

How do you get a prescription in India?

There are two routes:

1. Visit a specialist in person

An endocrinologist or bariatric physician can prescribe semaglutide after an in-person assessment. Wait times at reputable specialists in metro cities can be 2–4 weeks, and consultation fees typically range from ₹1,500 to ₹5,000 — before the cost of medication.

2. Online consultation via a registered telemedicine platform

Under India's Telemedicine Practice Guidelines (2020), licensed doctors can legally prescribe Schedule H drugs through video or audio consultation. Platforms like ZIVOLABS connect you with NMC-registered doctors who specialise in metabolic health. The process is faster, more private, and significantly more affordable.

ZIVOLABS process: Complete a health assessment → video consultation with a doctor → receive a valid digital prescription → medication dispatched via cold-chain delivery to your door, typically within 3–5 days.

Frequently asked questions

Is Ozempic the same as generic semaglutide? Yes. Ozempic is simply the brand name for the original semaglutide injection made by Novo Nordisk. Generic versions like Semasize and Semanat contain the identical active molecule at the same approved doses.

Can I buy semaglutide without a prescription? No. Semaglutide is classified as a Schedule H drug in India and legally requires a valid prescription from a registered doctor. Any source offering it without a prescription is operating illegally and the product may be unsafe.

Is online prescription for semaglutide legal in India? Yes. The Ministry of Health's Telemedicine Practice Guidelines (2020) permit doctors to prescribe Schedule H drugs via telemedicine after a proper consultation. The doctor must be registered with the National Medical Commission.

How long do I need to take semaglutide? Semaglutide is typically used for a minimum of 6 months to see meaningful results. Most medical protocols suggest continuing as long as the patient is responding well and tolerating the medication. Your doctor will guide the duration based on your individual progress.

What are the common side effects? The most common side effects are nausea, mild vomiting, and constipation — particularly in the first few weeks as your dose is increased. These usually resolve on their own. Serious side effects are rare and your doctor will discuss them during your consultation.

Ready to find out if you qualify?

Complete a free health assessment in under 5 minutes. A ZIVOLABS doctor will review your results and let you know if semaglutide is right for you.

[Check if I qualify →]

This article is for informational purposes only and does not constitute medical advice. Semaglutide is a prescription medication. Always consult a qualified doctor before starting any new treatment. Individual results may vary.